21-10541137-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000618007.5(TPTE):āc.37G>Cā(p.Val13Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000355 in 1,612,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 6/8 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000618007.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPTE | NM_199261.4 | c.37G>C | p.Val13Leu | missense_variant | 5/24 | ENST00000618007.5 | NP_954870.3 | |
TPTE | NM_199259.4 | c.37G>C | p.Val13Leu | missense_variant | 5/23 | NP_954868.2 | ||
TPTE | NM_199260.4 | c.37G>C | p.Val13Leu | missense_variant | 5/22 | NP_954869.2 | ||
TPTE | NM_001290224.2 | c.-182+13725G>C | intron_variant | NP_001277153.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPTE | ENST00000618007.5 | c.37G>C | p.Val13Leu | missense_variant | 5/24 | 1 | NM_199261.4 | ENSP00000484403 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152288Hom.: 0 Cov.: 61
GnomAD3 exomes AF: 0.000112 AC: 28AN: 251084Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135696
GnomAD4 exome AF: 0.000367 AC: 536AN: 1460364Hom.: 0 Cov.: 31 AF XY: 0.000387 AC XY: 281AN XY: 726552
GnomAD4 genome AF: 0.000243 AC: 37AN: 152288Hom.: 0 Cov.: 61 AF XY: 0.000255 AC XY: 19AN XY: 74408
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.37G>C (p.V13L) alteration is located in exon 5 (coding exon 2) of the TPTE gene. This alteration results from a G to C substitution at nucleotide position 37, causing the valine (V) at amino acid position 13 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at